Potential use of glioblastoma tumorsphere: Clinical credentialing

Seok Gu Kang; Jae Ho Cheong; Yong Min Huh; Eui Hyun Kim; Sun Ho Kim; Jong Hee Chang

doi:10.1007/s12272-015-0564-0

Potential use of glioblastoma tumorsphere: Clinical credentialing

Seok Gu Kang, Jae Ho Cheong, Yong Min Huh, Eui Hyun Kim, Sun Ho Kim, Jong Hee Chang

Research output: Contribution to journal › Review article › peer-review

22 Citations (Scopus)

Abstract

A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas.

Original language	English
Pages (from-to)	402-407
Number of pages	6
Journal	Archives of pharmacal research
Volume	38
Issue number	3
DOIs	https://doi.org/10.1007/s12272-015-0564-0
Publication status	Published - 2015 Mar

Bibliographical note

Publisher Copyright:
© 2015 The Pharmaceutical Society of Korea.

All Science Journal Classification (ASJC) codes

Molecular Medicine
Drug Discovery
Organic Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12272-015-0564-0

Cite this

@article{871ab6ce522b4c0fa2d207ce1643499b,

title = "Potential use of glioblastoma tumorsphere: Clinical credentialing",

abstract = "A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas.",

author = "Kang, {Seok Gu} and Cheong, {Jae Ho} and Huh, {Yong Min} and Kim, {Eui Hyun} and Kim, {Sun Ho} and Chang, {Jong Hee}",

note = "Publisher Copyright: {\textcopyright} 2015 The Pharmaceutical Society of Korea.",

year = "2015",

month = mar,

doi = "10.1007/s12272-015-0564-0",

language = "English",

volume = "38",

pages = "402--407",

journal = "Archives of pharmacal research",

issn = "0253-6269",

publisher = "Pharmaceutical Society of Korea",

number = "3",

}

TY - JOUR

T1 - Potential use of glioblastoma tumorsphere

T2 - Clinical credentialing

AU - Kang, Seok Gu

AU - Cheong, Jae Ho

AU - Huh, Yong Min

AU - Kim, Eui Hyun

AU - Kim, Sun Ho

AU - Chang, Jong Hee

PY - 2015/3

Y1 - 2015/3

N2 - A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas.

AB - A decade ago, cancer stem cells (CSCs) were introduced as target cells for an innovative cancer treatment. Particularly, there have been a lot of biological researches on glioblastoma (GBM) CSCs. However, as there is a comprehensive change in the concept of CSCs, it is required to review how the different CSCs for patients can be clinically used, or clinical credentialing, and summarize the possibilities of clinical credentialing. In this regard, this review aims to introduce the tumorsphere obtained from GBM specimen and summarize the clinical dilemma and clinically applicable areas.

UR - http://www.scopus.com/inward/record.url?scp=84925533611&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925533611&partnerID=8YFLogxK

U2 - 10.1007/s12272-015-0564-0

DO - 10.1007/s12272-015-0564-0

M3 - Review article

C2 - 25628248

AN - SCOPUS:84925533611

SN - 0253-6269

VL - 38

SP - 402

EP - 407

JO - Archives of pharmacal research

JF - Archives of pharmacal research

IS - 3

ER -

Potential use of glioblastoma tumorsphere: Clinical credentialing

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this